CONTINUE TO SITE

OR WAIT null SECS

Spotlight

Patient Participation Regulatory

Topic

View More Clinical Trial Supply Chain CRO/Sponsor eClinical EMA FDA

Clinical Trial Supply ChainCRO/SponsoreClinicalEMAFDA

News

Publications

All Publications Applied Clinical Trials E-Books

All PublicationsApplied Clinical TrialsE-Books

Media

Editorial Podcasts Editorial Videos Sponsored Podcasts Sponsored Videos

Editorial PodcastsEditorial VideosSponsored PodcastsSponsored Videos

Conferences

Conference Coverage Conference Listing

Columns

All Columns A Closing Thought Clinical Trial Insights View from Brussels View from Washington

All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington

Resources

Blogs Brand Insights Events Front & Center White Papers

BlogsBrand InsightsEventsFront & CenterWhite Papers

Webcasts

Enews Magazine

EnewsMagazine

Advertise
Contact Us
Editorial Contacts
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

Patient Participation
Regulatory

TopicSee All >

Clinical Trial Supply Chain
CRO/Sponsor
eClinical
EMA
FDA

Advertise
Contact Us
Editorial Contacts
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

SCOPE 2023: Venture Capital in Clinical Research

Published on: February 10, 2023

Andy Studna, Editor

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures discusses how 2023 could be a year of resurgence for venture dollars in clinical research following some retrenchment in 2022.

Breaking Historic Barriers to Ensure Psychedelic Therapy’s Future

Industry Seeks to Address Driving Force Behind United States’ Third Opioid Epidemic, Fentanyl

Harmonizing Outsourcing to Keep Clinical Trials on Track